Omission of axillary clearance

PROCEDURE2 trials

Sponsors

Karolinska Institutet

Conditions

Breast Cancer

Unknown Phase

Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis

CompletedNCT02049632

Karolinska InstitutetBreast Cancer

Start: 2013-12-31End: 2022-12-31Updated: 2023-03-10

Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.

Active, not recruitingNCT02240472

Karolinska InstitutetBreast Cancer

Start: 2015-01-27End: 2031-12-31Updated: 2026-07-14

Related Papers

Omission of completion axillary dissection in patients with breast cancer and sentinel lymph node macrometastases: Overall survival and patient-reported arm morbidity from the randomized SENOMAC trial.

Journal of Clinical Oncology2026-06-03

Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.

2024-12-018 citations

Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.

2024-08-0626 citations

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases

New England Journal of Medicine2024-04-03199 citations

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial.

2022-03-0141 citations

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

2020-01-279 citations

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.

2018-12-04108 citations